Tech Company Financing Transactions

Precision Therapeutics Funding Round

Precision Therapeutics secured a $43 million funding round on 11/10/2008. Investors included Longitude Capital Management, Adams Capital Management and Birchmere Ventures.

Transaction Overview

Company Name
Precision Therapeutics
Announced On
11/10/2008
Transaction Type
Venture Equity
Amount
$43,000,000
Round
Undisclosed
Investors

Longitude Capital Management (Lead Investor) (David Hirsch)

Adams Capital Management (Joel Adams)

Birchmere Ventures (Seán Sebastian)

Draper Triangle Ventures

Quaker Partners (Richard Kollender)

Proceeds Purpose
This funding will allow us to expand our penetration of the market and aggressively pursue new programs that will further enhance a physician's ability to determine individualized therapy regimens for patients in need.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2915 Commers Dr. 900
Eagan, MN 55121
USA
Phone
(651) 389-4800
Website
www.precisiontherapeutics.com
Email Address
[email protected]
Overview
Precision Therapeutics is an oncology services company dedicated to the individualization of cancer therapy. Precision Therapeutics is a leader in the development and delivery of treatment support tools that assist physicians and benefit cancer patients.
Profile
Precision Therapeutics LinkedIn Company Profile
Social Media
Precision Therapeutics Company Twitter Account
Company News
Precision Therapeutics News
Facebook
Precision Therapeutics on Facebook
YouTube
Precision Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Carl Schwartz
  Carl Schwartz LinkedIn Profile  Carl Schwartz Twitter Account  Carl Schwartz News  Carl Schwartz on Facebook
Chief Financial Officer
Robert Myers
  Robert Myers LinkedIn Profile  Robert Myers Twitter Account  Robert Myers News  Robert Myers on Facebook
Chief Operating Officer
David Johnson
  David Johnson LinkedIn Profile  David Johnson Twitter Account  David Johnson News  David Johnson on Facebook
VP - Product Management
David Dauwalter
  David Dauwalter LinkedIn Profile  David Dauwalter Twitter Account  David Dauwalter News  David Dauwalter on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/10/2008: Ruxton Pharmaceuticals venture capital transaction
Next: 11/10/2008: OzVision Global venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.